Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2026-03-12 to 2026-11-11
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$74.5M
across 2 rounds
CO-INVESTORS
16
named beside it
Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2026-03-12 to 2026-11-11
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Hangzhou Eli Radiopharma Co., Ltd. Eli Radiopharma specializes in the innovation of radioactive diagnostic and therapeutic drugs for cancer and neurodegenerative diseases. | Series A Verified against 4 of 12 sources | $60.0M | 2026-11-11 | [ PART ] |
Hangzhou Eli Radiopharma Co., Ltd. Eli Radiopharma specializes in the innovation of radioactive diagnostic and therapeutic drugs for cancer and neurodegenerative diseases. | Funding round Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $14.6M | 2026-03-12 | [ PART ] |